Actis, a leading private equity investor in emerging markets, is pleased to announce that it has raised US$475 million for investment in South Asia through its India Fund 2 and South Asia Fund 2.
Actis invests in the energy sector through its Energy Fund; its principal investment is in Globeleq
Actis Capital LLP is regulated in the United Kingdom by the Financial Services Authority
Actis is a new brand but an established business, created from CDC Capital Partners.
Actis has successfully exited its investment in Corporacion Fischel SA (Fischel), the largest pharmacy chain in Costa Rica with over 55 pharmacies and a presence in Nicaragua.
Actis will be established as an independent private equity manager when its demerger from CDC is effected in early 2004.